// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























28841 Abstracts

Optimal Insulin Correction Factor (ICF) for Post-exercise Hyperglycemia following High-Intensity Training in Adults with Type 1 Diabetes (T1D)—The FIT Study

RONNIE ARONSON - American Diabetes Association (ADA) , 2018

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

N/A

Insulin glargine

Liraglutide Effects in Insulin-Treated Patients in LEADER

CORNELIS TACK - American Diabetes Association (ADA) , 2018

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

N/A

Liraglutide

Early Effects of Sleeve Gastrectomy (SG) on Systemic and Organ-Specific Dietary Fatty Acid Uptake, Postprandial Free Fatty Acids (FFA), and Glucose Metabolism in Type 2 Diabetes (T2D)

ANNE-MARIE CARREAU - American Diabetes Association (ADA) , 2018

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

N/A

Palmitic acid

The Reference Distribution of Annual Change in Corneal Nerve Fibre Length in Diabetes Mellitus

EVAN J.H. LEWIS - American Diabetes Association (ADA) , 2018

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

N/A

N/A

Renal Hemodynamic Function at the Extremes of T1D Duration-Adolescents vs. Adults with T1D for =50 Years

YULIYA LYTVYN - American Diabetes Association (ADA) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Angiotensin II

NOD1 Mediates Insulin Resistance in Response to Circulating Free Fatty Acids

SYDNEY L. RIVERS - American Diabetes Association (ADA) , 2018

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

N/A

Palmitic acid

Elevated Serum Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Intrarenal Hemodynamic Dysfunction in Type 1 Diabetes (T1D)

PETTER BJORNSTAD - American Diabetes Association (ADA) , 2018

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

N/A

N/A

Dysglycemia Is as Common in Autoantibody-Negative Relatives as in Single-Autoantibody-Positive Relatives of Type 1 Diabetes (T1D) Patients

EMILY K. SIMS - American Diabetes Association (ADA) , 2018

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

N/A

N/A

MALAT1 and HOTAIR—Key Epigenetic Regulators in Diabetic Retinopathy

SAUMIK BISWAS - American Diabetes Association (ADA) , 2018

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

N/A

N/A

Empagliflozin Improves Renal Outcomes Irrespective of Control of Blood Pressure, Low-Density Lipoprotein Cholesterol, and HbA1c

CHRISTOPH WANNER - American Diabetes Association (ADA) , 2018

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

N/A

BI-10773

Higher Rates of Celiac Disease Serology and Biopsy Positivity in Adults with Type 1 Diabetes

FARID H. MAHMUD - American Diabetes Association (ADA) , 2018

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

N/A

N/A

Chronic Kidney Disease (CKD) and Risk of Mortality, Cardiovascular (CV) Events, and Severe Hypoglycemia in Type 2 Diabetes (T2D)-DEVOTE Results

ASLAM AMOD - American Diabetes Association (ADA) , 2018

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

N/A

Insulin glargine

Clinical Islet Transplantation Outcomes Are Comparable in Obese Type 1 Diabetes Recipients

ANNA LAM - American Diabetes Association (ADA) , 2018

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

N/A

N/A

The Relationships between Retinopathy and Other Vascular Complications in Adults with Long-Standing Diabetes—Results from the Canadian Study of Longevity in Type 1 Diabetes (T1D)

JULIE A. LOVSHIN - American Diabetes Association (ADA) , 2018

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

N/A

Angiotensin II

Successful Health Care Provider Strategies to Overcome Psychological Insulin Resistance in U.S. and Canada

TRICIA S. TANG - American Diabetes Association (ADA) , 2018

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

N/A

N/A

PBI-4547 Prevents Progression of Prediabetic Condition to Type 1 Diabetes in NOD Mice

FRANcOIS A. LEBLOND - American Diabetes Association (ADA) , 2018

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

N/A

N/A

PBI-4547 Reverses Diabetes and Metabolic Syndrome through Regulation of Lipid/Glucose Metabolism, ß-Oxidation and Fibrosis in Liver, and White Adipose Tissue in ob/ob Mice

LYNE GAGNON - American Diabetes Association (ADA) , 2018

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

N/A

N/A

RCT of Tailored Cognitive Behavioral Intervention Reduces Regimen-Related Distress—Relationship to Change in Medication Adherence and Glycemic Control at 12-Month Follow-Up

LESLEY LUTES - American Diabetes Association (ADA) , 2018

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

N/A

N/A

Histone H3 Serine 10 Phosphorylation Facilitates Endothelial Activation in Diabetic Kidney Disease

TAMADHER ALGHAMDI - American Diabetes Association (ADA) , 2018

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

N/A

Streptozotocin

Polygenic Risk Testing at the Time of Diagnosis of Diabetes Could Help Prevent Its Micro- and Macrovascular Complications

PAVEL HAMET - American Diabetes Association (ADA) , 2018

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

N/A

N/A

Copyright © 2026. QuantiNova All rights reserved